Year archive

RADIOPHARM THERANOSTICS LIMITED — 2024 filings

All 133 regulatory filings released by RADIOPHARM THERANOSTICS LIMITED (RAD) in 2024, sourced directly from the official regulator.

133 Filings

2024 Period

2024 filings (133)

Filing	Released	Lang
Strategic Co-Development Partnership with Lantheus for Aus 2 pages 168.3KB Regulatory Filings	2024-12-29	English
RAD 202 receives approval to start Phase 1 therapeutic trial 2 pages 93.0KB Regulatory Filings	2024-12-19	English
Response to ASX Aware Letter 5 pages 858.3KB Regulatory Filings	2024-12-18	English
Application for quotation of securities - RAD 6 pages 20.4KB Regulatory Filings	2024-12-18	English
Notice Under Section 708A 1 page 156.4KB Regulatory Filings	2024-12-18	English
Application for quotation of securities - RAD 6 pages 19.3KB Regulatory Filings	2024-12-17	English
Notification regarding unquoted securities - RAD 7 pages 20.9KB Regulatory Filings	2024-12-17	English
Change of Director's Interest Notices x7 21 pages 768.0KB Regulatory Filings	2024-12-17	English
Notification of cessation of securities - RAD 5 pages 16.7KB Regulatory Filings	2024-12-17	English
Completion of preclinical data package for RAD 402 2 pages 215.5KB Regulatory Filings	2024-12-09	English
Change of Director's Interest Notice PH 4 pages 191.0KB Regulatory Filings	2024-12-09	English
Notification of cessation of securities - RAD 5 pages 16.1KB Regulatory Filings	2024-12-01	English
Constitution 57 pages 905.2KB Regulatory Filings	2024-12-01	English
Radiopharm achieves Nasdaq listing of ADS 2 pages 218.7KB Regulatory Filings	2024-11-26	English
Presentation to Annual General Meeting 12 pages 750.5KB Regulatory Filings	2024-11-24	English
Results of Meeting 3 pages 134.1KB Regulatory Filings	2024-11-24	English
Approval received to expand RAD204 Phase 1 trial 2 pages 198.1KB Regulatory Filings	2024-11-18	English
RAD 301 shows strong imaging potential in pancreatic cancer 2 pages 283.1KB Regulatory Filings	2024-11-17	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.3MB Regulatory Filings	2024-10-28	English
Notice of Annual General Meeting 58 pages 976.5KB Regulatory Filings	2024-10-24	English
RAD 202 data presented at 2024 EANM Annual Meeting 2 pages 220.0KB Regulatory Filings	2024-10-22	English
Change of Director's Interest Notice - IT 3 pages 202.0KB Regulatory Filings	2024-10-22	English
BAMF Health to manufacture & dose for RAD101 Phase 2b trial 2 pages 218.9KB Regulatory Filings	2024-10-20	English
RAD partners with AtomVie to develop B7H3 trial doses 2 pages 244.2KB Regulatory Filings	2024-10-15	English
Significant progress with B7-H3 targeting radio-antibody 2 pages 195.3KB Regulatory Filings	2024-10-02	English
Initial Director's Interest Notice - ND 2 pages 248.4KB Regulatory Filings	2024-10-02	English
Appointment of Noel Donnelly as Non-Executive Director 2 pages 165.6KB Regulatory Filings	2024-10-01	English
RAD to present at JonesResearch Radiopharma Day 1 p Regulatory Filings	2024-10-01	English
Annual Report 110 pages 2.3MB Regulatory Filings	2024-09-29	English
Corporate Governance Statement and Appendix 4G 19 pages 619.0KB Regulatory Filings	2024-09-29	English
ESG Report 10 pages 495.2KB Regulatory Filings	2024-09-29	English
RAD Launching American Depositary Receipt (ADR) Program 3 pages 259.2KB Regulatory Filings	2024-09-18	English
Becoming a substantial holder (PH) 3 pages 200.9KB Regulatory Filings	2024-09-17	English
Change of Director's Interest Notice (x6) 17 pages 411.0KB Regulatory Filings	2024-09-17	English
Application for quotation of securities - RAD 8 pages 22.3KB Regulatory Filings	2024-09-12	English
Notice Under Section 708A 1 page 133.3KB Regulatory Filings	2024-09-12	English
Notification regarding unquoted securities - RAD 6 pages 19.6KB Regulatory Filings	2024-09-12	English
Appendix 4E and Preliminary Final Report 44 pages 1.3MB Regulatory Filings	2024-08-29	English
Application for quotation of securities - RAD 7 pages 19.9KB Regulatory Filings	2024-08-28	English
Change in substantial holding 4 pages 761.4KB Regulatory Filings	2024-08-28	English
Application for quotation of securities - RAD 7 pages 22.9KB Regulatory Filings	2024-08-27	English
Placement Options Range of Units and Top 20 Holders 3 pages 155.0KB Regulatory Filings	2024-08-27	English
Ceasing to be a substantial holder 2 pages 249.6KB Regulatory Filings	2024-08-26	English
Ceasing to be a substantial holder 3 pages 122.9KB Regulatory Filings	2024-08-26	English
Becoming a substantial holder 23 pages 917.1KB Regulatory Filings	2024-08-25	English
RAD increases ownership in Radiopharm Ventures to 75% 2 pages 224.6KB Regulatory Filings	2024-08-25	English
Application for quotation of securities - RAD 6 pages 18.7KB Regulatory Filings	2024-08-22	English
Notification regarding unquoted securities - RAD 6 pages 21.1KB Regulatory Filings	2024-08-22	English
Notice Under Section 708A 1 page 133.5KB Regulatory Filings	2024-08-22	English
Change in substantial holding 3 pages 97.5KB Regulatory Filings	2024-08-22	English
Change in substantial holding 4 pages 766.7KB Regulatory Filings	2024-08-22	English
Becoming a substantial holder 5 pages 122.7KB Regulatory Filings	2024-08-22	English
Application for quotation of securities - RAD 6 pages 18.7KB Regulatory Filings	2024-08-20	English
Notice Under Section 708A 1 page 133.2KB Regulatory Filings	2024-08-20	English
Application for quotation of securities - RAD 6 pages 18.7KB Regulatory Filings	2024-08-20	English
Notice Under Section 708A 1 page 133.4KB Regulatory Filings	2024-08-20	English
Dr Dimitris Voliotis appointed Chief Medical Officer 2 pages 166.5KB Regulatory Filings	2024-08-19	English
Presentation to Extraordinary General Meeting 10 pages 817.3KB Regulatory Filings	2024-08-13	English
Results of Extraordinary General Meeting 3 pages 134.4KB Regulatory Filings	2024-08-13	English
A$70m capital raising & Lantheus investment approved at EGM 2 pages 189.3KB Regulatory Filings	2024-08-13	English
Prospectus 51 pages 1.7MB Regulatory Filings	2024-08-08	English
Update - Proposed issue of securities - RAD 8 pages 28.3KB Regulatory Filings	2024-08-08	English
Update - Proposed issue of securities - RAD 7 pages 25.3KB Regulatory Filings	2024-08-08	English
Radiopharm receives US$2.0 M payment from Lantheus 2 pages 192.5KB Regulatory Filings	2024-08-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 847.5KB Regulatory Filings	2024-07-30	English
Radiopharm targets Nasdaq Listing by end of 2024 2 pages 173.6KB Regulatory Filings	2024-07-25	English
FDA IND approval for Phase 2b trial in brain metastases 2 pages 166.0KB Regulatory Filings	2024-07-22	English
Correction to Notice of Extraordinary General Meeting 3 pages 261.4KB Regulatory Filings	2024-07-16	English
Notice of Extraordinary General Meeting/Proxy Form 42 pages 816.6KB Regulatory Filings	2024-07-15	English
First patient dosed in Phase 1 therapeutic lung cancer trial 2 pages 218.7KB Regulatory Filings	2024-07-09	English
Ceasing to be a substantial holder 1 page 284.9KB Regulatory Filings	2024-07-07	English
Change in substantial holding PH 3 pages 289.8KB Regulatory Filings	2024-07-04	English
GN20 Disclosure 2 pages 623.1KB Regulatory Filings	2024-07-02	English
Becoming a substantial holder 4 pages 806.1KB Regulatory Filings	2024-07-02	English
Becoming a substantial holder 3 pages 635.2KB Regulatory Filings	2024-07-02	English
RAD notifies end of share agreements with Lind Partners 1 Regulatory Filings	2024-07-01	English
Notice Under Section 708A 1 page 133.2KB Regulatory Filings	2024-07-01	English
Application for quotation of securities - RAD 6 pages 18.5KB Regulatory Filings	2024-06-30	English
Investor webinar 3pm AEST Tuesday 2 July 1 page 161 Regulatory Filings	2024-06-26	English
Radiopharm Theranostics completes A$70 million placement 5 pages 250.7KB Regulatory Filings	2024-06-24	English
Lantheus Strategic Investment and Capital Raise Presentation 50 pages 4.1MB Regulatory Filings	2024-06-24	English
Proposed issue of securities - RAD 5 pages 18.4KB Regulatory Filings	2024-06-24	English
Proposed issue of securities - RAD 7 pages 25.2KB Regulatory Filings	2024-06-24	English
Reinstatement to Quotation 1 page 89.9KB Regulatory Filings	2024-06-24	English
Suspension from Quotation 2 pages 531.5KB Regulatory Filings	2024-06-23	English
Trading Halt 2 pages 195.8KB Regulatory Filings	2024-06-19	English
Radiopharm Receives Strategic Investment for up to A$18 mill 4 pages 224.2KB Regulatory Filings	2024-06-19	English
Proposed issue of securities - RAD 8 pages 28.2KB Regulatory Filings	2024-06-19	English
Change in substantial holding PH 3 pages 290.4KB Regulatory Filings	2024-05-22	English
Change in substantial holding NanoMab 2 pages 767.4KB Regulatory Filings	2024-05-22	English
Application for quotation of securities - RAD 6 pages 19.0KB Regulatory Filings	2024-05-15	English
Notice Under Section 708A 1 page 133.1KB Regulatory Filings	2024-05-15	English
RAD to be featured at B. Riley Securities Healthcare events 2 pages 244.3KB Regulatory Filings	2024-05-07	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.6MB Regulatory Filings	2024-04-29	English
Notification regarding unquoted securities - RAD 6 pages 19.8KB Regulatory Filings	2024-04-23	English
Radiopharm Ventures institutional & VC presentation 26 pages 2.6MB Regulatory Filings	2024-04-21	English
Presentation to Extraordinary General Meeting 8 pages 678.9KB Regulatory Filings	2024-04-14	English
Results of Extraordinary General Meeting 2 pages 129.8KB Regulatory Filings	2024-04-14	English
Application for quotation of securities - RAD 6 pages 18.4KB Regulatory Filings	2024-04-14	English
Notice Under Section 708A 1 page 132.8KB Regulatory Filings	2024-04-14	English
Board Changes 2 pages 192.3KB Regulatory Filings	2024-03-25	English
Final Director's Interest Notice MB 2 pages 282.9KB Regulatory Filings	2024-03-25	English
Initial Director's Interest Notice PH 2 pages 259.1KB Regulatory Filings	2024-03-25	English
RAD to present at NWR Virtual Healthcare Conference 2 pages 215.9KB Regulatory Filings	2024-03-18	English
Notice of Extraordinary General Meeting/Proxy Form 34 pages 834.3KB Regulatory Filings	2024-03-14	English
RAD 301 and 302 data shows value of targeting avb6-integrin 4 pages 405.7KB Regulatory Filings	2024-03-14	English
Application for quotation of securities - RAD 6 pages 18.6KB Regulatory Filings	2024-03-11	English
Notice Under Section 708A 1 page 133.2KB Regulatory Filings	2024-03-11	English
Multiple RAD301 data releases to be presented at EMIM 2 pages 268.3KB Regulatory Filings	2024-03-05	English
B Riley Securities Radiopharma Conference Presentation 16 pages 1.4MB Regulatory Filings	2024-03-03	English
Application for quotation of securities - RAD 6 pages 18.8KB Regulatory Filings	2024-03-03	English
Notice Under Section 708A 1 page 132.9KB Regulatory Filings	2024-03-03	English
Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301 2 pages 304.7KB Regulatory Filings	2024-02-28	English
Half Yearly Report and Accounts 45 pages 1.8MB Regulatory Filings	2024-02-28	English
Pilot Study Validates RAD Terbium-161 Radiotherapeutics 2 pages 283.1KB Regulatory Filings	2024-02-27	English
Participation in B. Riley Securities Radiopharma Conference 2 pages 214.5KB Regulatory Filings	2024-02-22	English
Radiopharm receives $1.9 M advance on FY24 R&D tax incentive 2 pages 155.7KB Regulatory Filings	2024-02-20	English
Application for quotation of securities - RAD 6 pages 18.7KB Regulatory Filings	2024-02-13	English
Notice Under Section 708A 1 page 133.0KB Regulatory Filings	2024-02-13	English
Application for quotation of securities - RAD 6 pages 18.7KB Regulatory Filings	2024-02-08	English
RAD secures Share Facility Agreement of up to A$12.5m 5 pages 334.7KB Regulatory Filings	2024-02-05	English
Proposed issue of securities - RAD 5 pages 17.9KB Regulatory Filings	2024-02-05	English
Proposed issue of securities - RAD 5 pages 17.8KB Regulatory Filings	2024-02-05	English
Proposed issue of securities - RAD 5 pages 19.6KB Regulatory Filings	2024-02-05	English
RAD Share Facility Agreement of up to A$12.5m addendum 6 pages 339.2KB Regulatory Filings	2024-02-05	English
Update - Proposed issue of securities - RAD 5 pages 18.2KB Regulatory Filings	2024-02-05	English
RAD 502 can halt tumour progression and prolong survival 2 pages 327.6KB Regulatory Filings	2024-02-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 417.7KB Regulatory Filings	2024-01-30	English
Application for quotation of securities - RAD 6 pages 28.1KB Regulatory Filings	2024-01-30	English
Placement of Entitlement Offer Shortfall 2 pages 228.4KB Regulatory Filings	2024-01-23	English
Investor Presentation 23 pages 1.9MB Regulatory Filings	2024-01-23	English
Application for quotation of securities - RAD 6 pages 28.5KB Regulatory Filings	2024-01-04	English
Notice Under Section 708A 1 page 133.0KB Regulatory Filings	2024-01-04	English